SPY311.36-0.82 -0.26%
DIA263.33+0.16 0.06%
IXIC9,615.81-67.10 -0.69%

SVB Leerink Maintains Market Perform on Teva Pharmaceutical Indus, Raises Price Target to $12

SVB Leerink maintains Teva Pharmaceutical Indus (NYSE:TEVA) with a Market Perform and raises the price target from $11 to $12.

Benzinga · 05/08/2020 17:05

SVB Leerink maintains Teva Pharmaceutical Indus (NYSE:TEVA) with a Market Perform and raises the price target from $11 to $12.